EUDR ToolsOutils publics gratuits pour les importateurs de l'UE
Bibliothèque du champ d'application SH/NC
Référence de codeproduits pharmaceutiques

Medicaments consisting of two or more constituents mixed together for therapeutic or prophylactic uses, not in measured doses or put up for retail sale (excl. goods of heading 3002, 3005 or 3006)

Référence datée à la source pour le code SH/NC 3003: sa base de champ d'application RDUE, sa hiérarchie NC, ses implications en matière de preuves et les lignes indexées liées.

Type de référenceFiche de champ d'application SH/NC
Décision de champ d'applicationOut of scope
Implication pour l'importateurNote de référence uniquement
Année NC2026
Réponse de référence

Le code SH/NC 3003 est hors champ d'application pour la préparation RDUE.

Medicaments consisting of two or more constituents mixed together for therapeutic or prophylactic uses, not in measured doses or put up for retail sale (excl. goods of heading 3002, 3005 or 3006) Le moteur de champ d'application indexé renvoie Out of scope pour ce code. No Annex I scope match was found for this indexed CN code.

Base du champ d'application

Pourquoi cette page de référence donne cette réponse.

Description du code
Medicaments consisting of two or more constituents mixed together for therapeutic or prophylactic uses, not in measured doses or put up for retail sale (excl. goods of heading 3002, 3005 or 3006)
Base annexe I
Aucune entrée directe à l'annexe I
Base de la source
Regulation (EU) 2023/1115 Annex I and CN 2026 index
Hiérarchie NC

Lignes parentes, filles et voisines.

La vue bibliothèque sert à la navigation de référence. Utilisez le vérificateur lorsque vous voulez lancer un autre code comme action.

30produits pharmaceutiquesout300310medicaments containing penicillins or derivatives thereof with a penicillanic acid structure, or streptomycins or derivatives thereof, not in measured doses or put up for retail saleout300320medicaments containing antibiotics, not in measured doses or put up for retail sale (excl. medicaments containing penicillins or derivatives thereof with a penicillanic acid structure, or streptomycins or derivatives thereof)out300331medicaments containing insulin, not in measured doses or put up for retail saleout300339medicaments containing hormones or steroids used as hormones, not containing antibiotics, not in measured doses or put up for retail sale (excl. those containing insulin)out300340medicaments containing alkaloids or derivatives thereof, not containing hormones, steroids used as hormones or antibiotics, not in measured doses or put up for retail saleout300341medicaments containing ephedrine or its salts, not containing hormones, steroids used as hormones or antibiotics, not in measured doses or put up for retail saleout300342medicaments containing pseudoephedrine (inn) or its salts, not containing hormones, steroids used as hormones or antibiotics, not in measured doses or put up for retail saleout300343medicaments containing norephedrine or its salts, not containing hormones, steroids used as hormones or antibiotics, not in measured doses or put up for retail saleout300349medicaments containing alkaloids or derivatives thereof, not containing hormones, steroids used as hormones or antibiotics, not in measured doses or put up for retail sale (excl. containing ephedrine, pseudoephedrine (inn), norephedrine or their salts)out300360medicaments containing any of the following antimalarial active principles: artemisinin (inn) for oral ingestion combined with other pharmaceutical active ingredients, or amodiaquine (inn); artelinic acid or its salts; artenimol (inn); artemotil (inn); artemether (inn); artesunate (inn); chloroquine (inn); dihydroartemisinin (inn); lumefantrine (inn); mefloquine (inn); piperaquine (inn); pyrimethamine (inn) or sulfadoxine (inn), not containing hormones, steroids used as hormones or antibiotics, not in measured doses or put up for retail saleout3001dried glands and other organs for organo-therapeutic uses, whether or not powdered; extracts of glands or other organs or their secretions, for organo-therapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, n.e.s.out3002human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excl. yeasts) and similar productsout3004medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale (excl. goods of heading 3002, 3005 or 3006)out3005wadding, gauze, bandages and the like, e.g. dressings, adhesive plasters, poultices, impregnated or covered with pharmaceutical substances or put up for retail sale for medical, surgical, dental or veterinary purposesout3006pharmaceutical preparations and products of subheadings 3006.10.10 to 3006.60.90out
Schéma de preuves

Ce que cela signifie pour la préparation.

Cette ligne ne déclenche pas directement de collecte de preuves dans le résultat de champ d'application actuel.

Métadonnées sources
Besoin de la vue action rapide?Lancez ce même code dans le vérificateur de champ SH.
Ouvrir le résultat de l'outil
3003 — Référence de champ d'application SH/NC RDUE | EUDR Tools